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THO is a protein complex that functions in cotranscriptional mRNP formation. Yeast THO1 and SUB2
(Saccharomyces cerevisiae) were identified as multicopy suppressors of the expression defects of the hpr1
mutant of THO. Here we show that multicopy THO1 suppresses the mRNA accumulation and export defects
and the hyperrecombination phenotype of THO mutants but not those of sub2, thp1, or spt4. Similarly,
Sub2 overexpression suppresses the RNA export defect of hpr1. Tho1 is a conserved RNA binding nuclear
protein that specifically binds to transcribed chromatin in a THO- and RNA-dependent manner and genetically
interacts with the shuttling hnRNP Nab2. The ability of Tho1 to suppress hpr1 resides in its C-terminal half,
which contains the RNA binding activity and is located after a SAP/SAF (scaffold-associated protein/scaffold-
associated factor) domain. Altogether, these results suggest that Tho1 is an hnRNP that, similarly to Sub2,
assembles onto the nascent mRNA during transcription and participates in mRNP biogenesis and export.
Overexpression of Tho1 or Sub2 may provide alternative ways for mRNP formation and export in the absence
of a functional THO complex.
Transcription is a central cellular function that occurs in the
nucleus of eukaryotic cells in coordination with other nuclear
processes. RNA polymerase II (RNAPII)-driven transcription
takes place in tight association with different mRNA process-
ing steps (46, 59). Indeed, a number of important proteins
involved in mRNA processing, such as the capping enzymes,
splicing factors, and the cleavage and polyadenylation stimu-
latory factor responsible for recognizing the poly(A) signal,
are loaded onto the nascent mRNA by interacting with the
C-terminal domain (CTD) of the RNAPII (43). Thus, in cell
extracts, a recombinant CTD stimulates poly(A) site cleavage
and mRNA splicing (22, 23) and influences 3-end formation
and capping of mRNAs (50, 55). The result of the combined
action of molecular processes is a mature mRNA-protein
(mRNP) particle proficient for nuclear export. Any failure
compromising the formation of an export-proficient mRNP
would likely trigger mRNA degradation by the nuclear exo-
some (28, 54), a process which may also occur cotranscription-
ally as shown in Drosophila spp. (6). The nuclear integration of
the different processes taking place from transcription to
mRNA export was recently observed at the cellular level by the
nuclear pore colocalization of actively transcribed GAL genes
(8).
An intriguing connection of mRNP biogenesis with other
nuclear processes is that observed with genetic stability. Even
though there is accumulated evidence for the stimulation of
both mutation and recombination by transcription, the func-
tional and physical interconnection between mRNP biogenesis
and genetic instability comes from studies with the THO com-
plex of Saccharomyces cerevisiae (2, 3). THO is a four-protein
complex composed of stoichiometric amounts of Tho2, Hpr1,
Mft1, and Thp2 (10). Null mutations of any component of
THO lead to similar phenotypes of transcription impairment,
transcription-associated hyperrecombination and RNA export
defects (9, 10, 29, 53), and increased levels of exosome-depen-
dent mRNA instability (37, 58). THO has also been purified in
humans and Drosophila, and the two major subunits, Tho2 and
Hpr1, are present in all of the eukaryotes studied (10, 47, 53).
Furthermore, THO forms, together with the RNA export pro-
teins Sub2/UAP56 and Yra1/Aly, a larger complex termed
TREX, as identified in yeast (Saccharomyces cerevisiae) and
humans (53). In addition to the physical interaction, there is a
functional interaction between Sub2, Yra1, and the THO com-
plex. Thus, mutant alleles of SUB2 and YRA1 are synthetic
lethal with THO mutations and lead to the same transcription-
dependent hyperrecombination and gene expression pheno-
types as do THO mutations. In addition, Sub2 overexpression
suppresses hpr1 (13, 29, 53). THO, Sub2, and Yra1 are re-
cruited to active chromatin in a way in which THO seems to be
recruited first to facilitate the subsequent recruitment of Sub2
and Yra1 (36, 53, 58).
The connection between mRNP biogenesis factors and the
origin of genetic instability is also provided by the yeast Thp1-
Sac3 complex involved in RNA export and located in the
proximity of the nuclear pore complex (14), the Mex67-Mtr2
export factor, or the Nab2 hnRNP. Mutations in these factors
confer transcription, RNA export, and hyperrecombination
phenotypes similar to those of mutants of the THO complex
(15, 16, 29).
One major cause for the transcription impairment and hy-
perrecombination phenotypes of THO mutants is the cotrans-
criptional accumulation of DNA-RNA hybrids formed behind
the elongating RNAPII in the absence of functional THO. This
indicates that one role of THO/TREX in mRNP assembly may
be to maintain the nascent mRNA apart from the transcribed
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DNA, impeding undesired interactions of the nascent mRNA
with the DNA template (24).
One way of understanding the functional interaction be-
tween genetic instability and mRNP biogenesis in general, and
the THO complex in particular, has been through the isolation
and analysis of multicopy suppressors. Thus, the Sub2 RNA
export factor, a putative RNA-dependent ATPase with homol-
ogy to RNA helicases (32), was found as a multicopy suppres-
sor of hpr1 (13, 29). In addition, a new gene of unknown
function, THO1, was identified as a multicopy suppressor of
hpr1 in two different screenings (29, 45). No phenotype has
been associated so far with the null mutants of THO1 to pro-
vide clues about its in vivo function (45). Here we show that
Tho1 is a novel nuclear hnRNP that binds RNA in vitro and is
recruited to transcribed chromatin in vivo in a THO-complex-
and RNA-dependent manner. Tho1 overexpression suppresses
the recombination, RNA export, and gene expression defects
of THO mutants but not those of sub2 mutants. Multicopy
SUB2 also suppresses the RNA export defect of hpr1 strains.
The ability of Tho1 to suppress hpr1 resides in its RNA
binding C-terminal region. Altogether, our study suggests that
Tho1, like Sub2, assembles onto the nascent mRNA during
transcription and that Tho1 and Sub2 can provide alternative
ways for mRNP biogenesis in the absence of a functional THO
complex.
MATERIALS AND METHODS
Strains. Yeast strains used were the previously described W303-1A (wild type)
U678-1C (hpr1::HIS3), AYW3-3C (hpr1::HIS3), WRK-1C (tho2::KanMX4),
RK2-6C (tho2::KanMX4), AW33-11Bu (tho1::TRP1) (45), sub2 (sub2::HIS3)
(27, 29, 38), Sub2-TAP (SUB2-TAP) (53), MFM67-13A (mft1::KanMX4) (10) and
WMK-2A (mft1::KanMX4) (10), and the BY4741 (wild type) and its isogenic thp2
mutant BY-HR167 (EUROSCARF, Frankfurt, Germany) (10), plus the strains
constructed for this study, SUL-1A (MAT ade2 his3 trp1 ura3 sub2 HIS3 leu2-k::
URA3-ADE2::leu2-k), BSU-S2T-3B (MAT his3 trp1 ura3 leu2-k::URA3-ADE2::
leu2-k SUB2-TAP), BSU-S2T-6D (MATa his3 trp1 ura3 hpr1::HIS3 SUB2-TAP),
WWT1T and WWT2T (W303 carrying TAP-tagged Tho1 and Tho2, respectively),
WHT1T (hpr1::HIS3) carrying TAP-tagged Tho1, WWYL.1D (wild type) and
WHYL.2A (hpr1::HIS3) carrying the GAL1pr::YLR454c fusion (53), and NALT-1
and NALT-2 (mutant nab2-1 and double mutant tho1 nab2-1), obtained by genetic
crosses between AW33-11Bu and nab2-1 (20).
The chromosomal THO1-TAP fusion was constructed by transforming W303-1A
with the 1.17-kb, 5-end TAP-tagged THO1 sequence obtained by PCR on plasmid
pBS1479 (48) using the primers 5-TCCAGAGTAAGTAAAAACAGGAGAGGC
AACCGCTCTGGTTACAGAAGATCCATGGAAAAGAGAAG-3 and 5AAA
GAACCGAAACTAGAATGAAAAACTCCACCAAAACGGCTTGAGCCTTC
GACTCACTATAGGG-3. Constructions of SUB2-TAP and THO2-TAP were
described previously (29, 53).
Plasmids. Plasmids pCM184-LAUR and p416GAL1lacZ have been described
previously (9, 29). Plasmid pT7-HA-THO1, containing an N-terminal His6- hem-
agglutinin (HA) translational fusion of the complete THO1 coding sequence
under the control of the T7 RNA pol promoter, was constructed by inserting into
the NheI-ClaI site of pT7-7-His6 a 0.72-kb HA-THO1 fragment obtained by PCR
using 5-GGGTACATGTGCTAGCTATCCCTATGACGTTCCCGACTATGC
TATGGCAGATTATTCTTC-3 and 5-TACTCCAAGCTTATCGATGCCTT
TATCTTCTGTAACCAG-3 as primers. Plasmids pT7-HA-5THO1 and pT7-
HA-3THO1 are identical to pT7-HA-THO1 except for containing the 0.21-kb
5-end and 0.54-kb 3-end fragments of THO1, respectively. Such copies were
obtained by PCR using 5-GGGTACATGTGCTAGCTATCCCTATGACGTT
CCCGACTA-3 and 5-GCTAAGGCCCAAGCTTCCTGTGGAGAAACTTC
ACTTTCAC-3 as primers for 5THO1 and 5-CGGCATGCAGCTAGCGAA
CAAAACCAGGAACAAGGGTCAG-3 and 5-TACTCCAAGCTTATCGAT
GCCTTTATCTTCTGTAACCAGA-3 as primers for 3THO1.
Plasmids pGAL-THO1, pGAL-NTHO1, and pGAL-THO1C were con-
structed by inserting the respective XbaI-ClaI inserts from the pT7-7His6 plas-
mids into p416GAL based on pRS416 containing the GAL1 promoter.
Purification of recombinant Tho1 proteins from Escherichia coli. BL21(DE3)
strains transformed with pT7-HA-THO1, pT7-HA-5THO1, and pT7-HA-
3THO1 were grown in LB medium with 100 g/ml ampicillin to an optical
density at 600 nm (OD600) of 0.8. Expression of the T7 promoter was induced for
4 h by adding IPTG (isopropyl--D-thiogalactopyranoside) to a final concentra-
tion of 1 mM. Proteins were purified from the lysates by affinity chromatography
on a Ni-nitrilotriacetic acid column (QIAGEN) according to the manufacturer’s
instructions and quantified by Lowry’s method.
In situ mRNA export assays. In situ localization of poly(A) RNA was performed
as described previously (5) using a digoxigenin-labeled oligo(dT)16 probe.
In vitro RNA binding activity. RNA binding activity was determined in vitro by
RNA band-shifting assays following previously published procedures. As 32P-
labeled and cold nucleic acid samples, we used the 90-mer RNA sequence from
the polylinker of pBluescript-SK and the 60-mer single-stranded DNA (ssDNA)
previously described (29).
Chromatin immunoprecipitation. For chromatin immunoprecipitation (ChIP)
analyses, either the yeast strains WW-T1T and WHT1T, WWT2T, and Sub2-
TAP containing the THO1-TAP, THO2-TAP, and SUB2-TAP, respectively, or
the yeast strains WWYL.1D and WHYL.2A carrying the GAL1pr::YLR454c
fusion were used. For ChIP analyses with PMA1, strains were grown in yeast
extract-peptone-dextrose at 30°C up to an OD660 of 0.8. For ChIP with GAL1
and GAL1pr::YLR454c genes, strains were grown in synthetic complete (SC)–2%
glycerol–2% lactate to an OD660 of 0.5. The culture was split in two, one half was
supplemented with 2% glucose (repressed transcription) and the other with 2%
galactose (activated transcription). Samples were taken after 3 h. ChIP assays
were performed as described previously (21). RNase treatment was made with
300 U of RNase T1 and 300 U of RNase A for 2 h at 30°C before immunopre-
cipitation. For experiments with RNase treatment, the time for cross-linking was
reduced from 15 to 4 min. Immunoprecipitations were performed by using
immunoglobulin-Sepharose for tandem affinity purification (TAP)-tagged pro-
teins and the monoclonal anti-Rpb1-CTD antibody 8WG16 (Berkeley Antibody
Company) and protein A-Sepharose for RNAPII. The GFX purification system
(Amersham) was used for the last DNA purification step. We used 20- to 27-bp
oligonucleotides for the PCR amplification of four fragments of GAL1, five
fragments of PMA1, and three fragments of YLR454c, as indicated, and of the bp
9716 to 9863 intergenic region of chromosome V that was used as a negative
control. The PCR products obtained were electrophoresed in a 15% acrylamide
gel, stained with ethidium bromide, and quantified in a Fuji FLA-3000. For
quantification of each ChIP assay, the linear range of each PCR amplification
was first established with serial dilutions of the total input (I) and immunopre-
cipitated (P) DNA. Calculations and normalization of each ChIP were carried
out as previously described (4, 30, 33). Briefly, we first performed PCR ampli-
fication experiments using different DNA dilutions, so that conditions were
established to perform all definitive PCR amplification experiments in the linear
range (see Fig. S1 in the supplemental material). The enrichment of the PCR
amplification of interest above background levels was calculated by dividing the
ratio “gene-specific P signal/intergenic P signal” between the ratio “gene-specific
I signal/intergenic I signal.” All experiments were performed at least three times
within the linear range with similar results.
Miscellaneous. Recombination frequencies were obtained from two to three
different transformants for each genotype tested. The median frequency of 6 to 12
independent values for each transformant was determined as reported previously
(29). Northern analyses were performed according to standard procedures.
RESULTS
Multicopy THO1 and SUB2 suppress all phenotypes of
hpr1 mutants. For the isolation of multicopy suppressors of
hpr1, we used the LAUR gene expression system containing
a 4.15-kb lacZ-URA3 translational fusion under the control of
the tet promoter (29). Whereas wild-type cells can express this
fusion construct properly, this is not the case for THO mutants.
Thus, hpr1 cells carrying the LAUR system were unable to
form colonies on synthetic medium lacking uracil (SC-Ura-
Trp-Leu) and did not express -galactosidase activity. With
this assay, we obtained different overlapping clones that de-
fined only two genes that suppressed hpr1 in multicopy,
SUB2, whose analysis was previously reported (29), and THO1,
a novel gene of unknown function that we have previously
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found as a multicopy suppressor of the hpr1 thermosensitivity
and gene expression phenotype (45). In silico analysis revealed
that Tho1 has a N-terminal DNA binding domain, termed the
SAP domain, that is conserved in eukaryotes and present in a
number of scaffold-associated proteins involved in RNA and
DNA metabolism (7) (see Fig. S2 in the supplemental mate-
rial). Interestingly, our in silico analysis revealed that the human
ortholog of Tho1 is likely the Hcc-1 protein (see Fig. S2 in the
supplemental material), which was identified as a highly ex-
pressed protein in human hepatocarcinoma and which has been
shown in two-hybrid assays to bind the two DEAD box putative
RNA helicases, hSUB2/UAP56/BAT1 and DDX39 (12, 35).
As previously shown for multicopy SUB2, we show that
hpr1 cells carrying the LAUR system and THO1 in multicopy
FIG. 1. Suppression of the gene expression, hyperrecombination, and RNA export phenotypes of hpr1 by multicopy THO1 and SUB2. (A) Analysis
of the capacity of hpr1 (U678-4C) and sub2 (sub2) cells carrying the Ptet::lacZ-URA3 construct to form colonies in SC lacking Ura (sub2 cells are
slow-growing but viable null sub2 Ura mutants (29) derived from W303 isogenic strain DLY23 (27, 38). The cells analyzed were transformants with the
empty multicopy vector YEp351 (YEp, negative control) or YEp351-HPR1 (YEp-HPR1, positive control), YEp351-THO1 (YEp-THO1) or YEp351-
SUB2 (YEp-SUB2) carrying the HPR1, THO1, and SUB2 genes, respectively. The top panel shows a scheme of the Ptet::lacZ-URA3 translational fusion
used to study expression of lacZ and URA3. (B) Northern analyses of the same hpr1 transformant strains shown in panel A. RNA was isolated from
mid-log-phase cultures grown in SC lacking Trp and Leu. As a 32P-labeled DNA probe we used the 3-kb BamHI lacZ fragment and an internal 589-bp
25S rRNA fragment obtained by PCR. mRNA quantifications were performed in a Fuji FLA3000 and normalized with respect to the rRNA levels of
each sample, and are given in arbitrary units (AU) (C) Recombination frequency of the intrachromosomal direct-repeat system leu2-k::URA3-ADE2::
leu2-k in hpr1 (U678-4C) and sub2 (SUL-1A) mutants transformed with multicopy vector YEp351 and YEp351-THO1. The top panel shows a scheme
of the recombination assay used. Recombination frequencies are the median value of a total of 12 independent colonies obtained from SC lacking Leu.
Ura recombinants were selected in SC plus 5-fluoroorotic acid plates. (D) Subcellular localization of poly(A) RNAs detected in situ with digoxigenin-
labeled oligo(dT)16. Samples were taken from mid-log-phase cultures of hpr1 (U678-4C) cells transformed with either YEp351, YEp351-THO1 or
YEp351-SUB2 and shifted to 37° for 4 h in SC lacking Leu. Nuclei (DNA) were visualized by staining with 10 g/ml DAPI (4,6-diamidino-2-
phenylindole). Analyses were performed with an Olympus AHBT3 microscope.
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recovered the abilities to grow on SC-Ura-Trp-Leu and express
-galactosidase activity (Fig. 1A; data not shown). This sup-
pression occurs at the level of mRNA accumulation, as shown
by Northern analysis. As can be seen in Fig. 1B, hpr1 cells
were able to significantly increase the levels of lacZ-URA3
mRNA accumulation when expressing THO1 in multicopy.
In addition to the gene expression defect, two other hall-
mark phenotypes of THO mutants are the hyperrecombination
and mRNA export defect phenotypes. If multicopy THO1 sup-
pressed the absence of the THO complex in the cell directly
and not just the gene expression defect of hpr1 cells in an
indirect manner, the recombination and mRNA export phe-
notypes of hpr1 might also be suppressed. To test this, we
determined the frequency of direct-repeat recombination in
the chromosomal leu2-k::URA3-ADE2::leu2-k system and the
subcellular localization of bulk poly(A) RNA in mutant cells
transformed with the YEp351-THO1 multicopy plasmid. As
can be seen in Fig. 1C, recombination levels in hpr1 cells
carrying THO1 in multicopy were sevenfold lower than those in
hpr1 cells transformed with the empty multicopy vector
FIG. 2. Suppression of different phenotypes of THO mutants by multicopy THO1. (A) Northern analyses of tho2 (RK2-6C), mft1 (WMK-
2A) cells carrying the Ptet::lacZ-URA3 construct, and thp2 (BY-HR167) carrying the GAL1pr::lacZ construct under transcription activation
conditions. (B) Recombination frequency of the intrachromosomal direct-repeat system leu2-k::URA3-ADE2::leu2-k mft1 (MFM67-13A) and
tho2 (WRK-1C) mutants transformed with multicopy vector YEp351 and YEp351-THO1. Details are as described for Fig. 1. (C) Suppression
of the thermosensitivity (ts) phenotype of hpr1, tho2, mft1 and thp2 by multicopy THO1. Viability of hpr1 (U678-4C) tho2 (WRK-1C),
mft1 (MFM67-13A), and thp2 (BY-HR167) cells transformed with either YEp351 or YEp351-THO1. As controls, we used wild-type (WT)
W303-1A and BY4741. As they gave identical results, only one is shown. Transformants were spotted as 10-fold serial dilutions on selective
medium. Photographs were taken after 3 or 5 days at 30 or 37°C, respectively, as indicated.
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YEp351. In a previous study (45), we did not detect a signifi-
cant suppression of hyperrecombination of the first THO1
clone obtained. Apparently, as we now found a sixfold reduc-
tion in the recombination of hpr1 using a different E. coli-
amplified clone from that study (data not shown), the E. coli-
amplified clone used in that previous study accumulated some
mutation that limited its capacity to reduce hyperrecombina-
tion. In contrast, multicopy THO1 was able to suppress neither
the gene expression defect (Fig. 1A) nor the high levels of
recombination (Fig. 1C) of sub2 cells. It is important to note
that we used slow-growing but viable sub2 strains isogenic to
W303-1A that were previously shown to be viable (38). The
ability of multicopy SUB2 to suppress the hyperrecombination
of hpr1 cells was reported previously (13).
In situ localization of poly(A) RNA by digoxigenin-labeled
oligo(dT) revealed that hpr1 cells accumulated poly(A)
RNA in the nucleus after 4 h of shifting to 37° if transformed
with YEp351 and in both the nucleus and the cytoplasm if
transformed with multicopy YEp351-THO1 (Fig. 1D). Similar
results were obtained with multicopy YEp351-SUB2 carrying
SUB2 (Fig. 1D). Therefore, the RNA export defect of hpr1
cells was also suppressed by multicopy THO1 and SUB2.
Multicopy THO1 suppresses all mutants of the THO com-
plex. In order to determine whether THO1 suppression was
specific to hpr1 or general to other mutants of the THO
complex, we tested the ability of multicopy THO1 to suppress
different phenotypes of the other three THO-null mutants,
tho2, mft1, and thp2. As can be seen in Fig. 2, multicopy
THO1 partially suppressed the incapacity of tho2 and mft1
to express the lacZ-URA3 construct to different degrees as
determined by uracil prototrophy (data not shown) and North-
ern analysis (Fig. 2A). The suppression of gene expression
phenotypes was also observed in thp2 strains (Fig. 2A), in
which case Northern analyses were performed with the GAL1-
lacZ system because the genetic markers of the thp2 strains
were incompatible with those of the lacZ-URA3 construct.
Hyperrecombination was reduced 19.4- and 16.6-fold in tho2
and mft1, respectively (Fig. 2B). Finally, the ability of multi-
copy THO1 to suppress all THO mutants was tested with the
thermosensitivity (ts) phenotype. As can be seen in Fig. 2C, the
ts phenotype of all THO-null mutants (hpr1, tho2, mft1,
and thp2) was suppressed by multicopy THO1. These results
are in agreement with the observation that THO is a structural
and functional unit (10) as suppression is observed for all
phenotypes. Nevertheless, the variability observed in the inten-
sity of suppression may reflect a difference in the in vivo rele-
vance of each subunit for each phenotype tested, in particular
in the presence of multicopy THO1.
The suppression effect of multicopy THO1 was specific to the
THO complex mutants, since null mutations of THP1 and SPT4,
involved in RNA export and/or transcription and with effects on
mRNA accumulation similar to those of THO mutants, were not
suppressed by multicopy THO1 (data not shown). The fact that
multicopy THO1 suppresses the different phenotypes of THO
mutants and not those of sub2 suggests a functional relationship
of Tho1 with THO rather than with TREX. Nevertheless, in
contrast to THO mutations and to sub2 cells, tho1 did not have
any effect on direct-repeat recombination and gene expression or
on mRNA export (45; data not shown).
hpr1 mutants show reduced processivity of transcription
elongation that is suppressed by multicopy THO1 or SUB2.
Mutants of the THO complex are impaired in transcription
elongation as determined in vivo and in vitro (9, 41, 49). To
specifically analyze transcription impairment in THO mutants
in vivo independently of any possible effect in RNA stability,
FIG. 3. Analysis of the distribution of RNAPII along the GAL1pr::
YLR454c fusion construct located at the endogenous YLR454c chromo-
somal locus. (A) ChIP analysis in wild-type (WT) and hpr1 isogenic
strains. (B) ChIP analysis in hpr1 cells transformed with YEp351-HPR1,
YEp351, YEp351-THO1, or YEp351-SUB2. Strains used were
WWYL-1D (WT) and WHYL-2A (hpr1). The scheme of the gene
analyzed and the PCR-amplified fragments are shown. All experiments
were performed with two different transformants. ChIPs were repeated
three times for each sample. One representative acrylamide electrophore-
sis for each experiment is shown. The other fragments correspond to the
DNA regions studied. The relative abundance of each DNA fragment was
calculated as the ratio between each DNA fragment and the intergenic
region quantification results of the precipitated fractions (P) normalized
with respect to the corresponding ratios of the input fractions (I). The
recruitment data shown are referred to the value of the 5 region, taken
as 100%. Error bars indicate standard deviations. The PCR fragment
corresponding to the bp 9716 to 9863 intergenic region of chromosome V
used as a control is indicated by asterisks. m, middle.
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we determined RNAPII recruitment by ChIP analysis. This
was performed at the 8-kb-long YLR454c gene fused to the
GAL1 promoter in three different regions (5 end, middle, and
3 end). Consistent with recent results (41), Fig. 3A shows that,
whereas more than 95% of RNAPIIs reached the 3 end of the
gene in wild-type cells, this value was reduced to 50% in hpr1
mutants, indicating that the processivity of transcription elon-
gation is decreased in THO mutants. Importantly, Tho1 and
Sub2 overexpression suppressed this transcription processivity
defect of hpr1 cells (Fig. 3B). Altogether, the ability of Tho1
to suppress all phenotypes of THO mutants indicates that the
Tho1 and the THO complex must function at the same mo-
lecular level.
Tho1 is a conserved nuclear protein that binds to actively
transcribed chromatin in a THO- and RNA-dependent man-
ner. As expected from the nuclear localization of the THO
complex (10), Tho1 is predominantly nuclear, as we have
shown with an N-terminal Tho1-GFP fusion (data not shown),
and as has been observed in a high-throughput analysis (18).
We next wondered if Tho1, as previously shown for THO/
TREX, was present in actively transcribed chromatin. This was
determined by ChIP assays using yeast strains containing the
TAP-tagged version of THO1 at the chromosomal locus. We
studied the distribution of Tho1 at four different positions of
the GAL1 locus: the promoter 5 end of the coding region, the
middle part of the open reading frame, the 3 end of the open
reading frame, and the untranslated 3-end region (UTR) of
the gene. As can be seen in Fig. 4A, there was no amplification
of the DNA sequences analyzed when GAL1 was repressed
(2% glucose), indicating no recruitment of Tho1 to inactive
chromatin. However, the recruitment of Tho1 to GAL1 chro-
matin was observed when transcription was active. Recruit-
ment was poor at the promoter 5-end region and high in the
rest of the regions tested. The largest recruitment of Tho1 was
observed at the 3 end of the coding region, with its presence
being reduced at the UTR.
To test whether the recruitment of Tho1 was specific for the
regulated GAL genes, we extended the ChIP analysis to the
constitutively transcribed PMA1 gene. Five different regions of
PMA1 were analyzed: the promoter, the 5 end, the middle
part, and the 3 end of the coding sequence, and the 3 UTR.
As can be seen in Fig. 4B, poor but detectable recruitment of
Tho1 was observed at the promoter, the 5 end of the coding
sequence, and the UTR, and as in the GAL1 gene, recruitment
of Tho1 was higher toward the 3 end of the coding sequence.
Therefore, we can conclude that Tho1 is recruited to active
chromatin regardless of whether it is regulated (GAL1) or
constitutive (PMA1).
As has been shown recently for Sub2 (1), we wondered
whether Tho1 recruitment to transcribed chromatin was de-
pendent on the THO complex and on the nascent RNA. To
assay whether the THO complex was required or whether it
FIG. 4. Tho1 binds to actively transcribed chromatin in a THO-
and RNA-dependent manner. The scheme of the genes analyzed and
the PCR fragments amplified by PCR are shown. One representative
acrylamide electrophoresis for each experiment is shown, with the
PCR fragment corresponding to the bp 9716 to 9863 intergenic region
of chromosome V used as a control indicated with asterisks. (A) ChIP
analysis of Tho1 at the endogenous GAL1 gene in the wild-type strain
WWT1T. (B) ChIP analysis of Tho1 at the endogenous PMA1 gene in
the wild-type (WT) WWT1T strains carrying the TAP-tagged Tho1.
(C) Importance of the THO complex for the recruitment of Tho1 to
chromatin at the PMA1 gene, as determined by comparative ChIP
analysis in the wild type (WWT1T) and hpr1 mutant (WHT1T)
(D) Effect of RNase treatment on Tho1 and Tho2 recruitment to
active chromatin at the PMA1 gene, as determined by modified ChIP
analyses. These were performed in the wild-type WWT1T and
WWT2T strains, carrying TAP-tagged Tho1 and Tho2, respectively,
treated with () or without () RNase before immunoprecipitation.
Cross-linking times were reduced to 4 min in either treated or non-
treated samples. (E) Northern analyses of the expression of PMA1 in
WT and hpr1 congenic strains RNA was isolated from mid-log-phase
cultures grown in rich media. As a 32P-labeled DNA probe, we used
the 2.7-kb PMA1 fragment and an internal 589-bp 25S rRNA fragment,
both obtained by PCR. Other details are as described for Fig. 1 and 2.
AU, arbitrary units. Error bars indicate standard deviations.
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enhanced recruitment of Tho1 to active chromatin, we com-
pared the results of the ChIP analysis of Tho1-TAP in wild-
type and hpr1 strains. As can be seen in Fig. 4C, Tho1 re-
cruitment was clearly reduced in hpr1 cells, suggesting that
the THO complex is required for Tho1 recruitment. To rule
out the possibility that the THO dependency of Tho1 recruit-
ment to chromatin was due to an incapacity of hpr1 to tran-
scribe PMA1, we analyzed the levels of PMA1 transcription by
Northern analysis and found that they were only slightly re-
duced in hpr1 versus wild-type cells (Fig. 4E). This was ex-
pected, as we had previously shown that the effect of hpr1 on
transcription is significant in highly transcribed long or GC-
rich DNA sequences (11), whereas PMA1 does not belong to
this class of genes, and is consistent with previous Northern
analyses of PMA1 in hpr1 strains (58).
To determine whether the Tho1 recruitment is RNA depen-
dent, a ChIP analysis was performed with or without RNases A
and T1 before immunoprecipitation. Given that Tho2 recruit-
ment was reported to be independent of RNA (1), we used a
TAP-tagged Tho2 protein as a negative control. As can be seen
in Fig. 4D, in RNase-treated samples, Tho1 recruitment to the
PMA1 gene was abolished, whereas Tho2 was strongly re-
cruited. As expected in these experiments, Sub2 recruitment
was also reduced after RNase treatment (data not shown).
Tho1 recruitment to transcribed chromatin is therefore depen-
dent on THO and RNA.
FIG. 5. In vitro RNA binding activity of Tho1. (A) Twelve percent sodium dodecyl sulfate-polyacrylamide gel electrophoresis of a His6-tagged
version of the complete Tho1 protein and its truncated N-Tho1 and Tho1-C forms obtained from E. coli and stained with Coomassie blue. Proteins
were purified from the BL21 E. coli strain transformed with pT7-HA-THO1, pT7-HA-5THO1, and pT7-HA-3THO1. A scheme of each protein
purified is shown on the right, with the SAP domain shown in gray. (B) Band shift assays of the RNA binding activity of Tho1 using 5 ng of the
90-bp, 32P-labeled RNA from the polylinker of pBluescript-SK (0.05 M 107) and increasing amounts of purified Tho1. (C) Competition assays
of RNA binding activity using increasing amounts of the same 90-mer RNA molecule used before and a 60-mer ssDNA as cold competitor.
(D) RNA binding assays with increasing equimolecular amounts of the N-Tho1 and Tho1-C truncated forms of Tho1. Other details are as
described for panel B. (E) Comparison of the ability to suppress the thermosensitivity (ts) phenotype of hpr1 by overexpression of truncated Tho1
versions. Viability of hpr1 (U678-4C) cells transformed with either pGAL-THO1, pGAL-NTHO1, and pGAL-THO1C or the empty vector
p416GAL (pGAL). Transformants were spotted on selective medium with glucose to control for cell number and on galactose-containing medium
to induce gene expression. Other details are as described for Fig. 2. WT, wild type.
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In vitro RNA binding activity of Tho1. Given all of the
previous results, we wondered if Tho1 had the ability to bind
RNA in vitro. Since Tho1 has two structurally different halves,
the N-terminal region that contains the SAP/SAF domain and
the C-terminal half, with no known domain, we constructed
His6-tagged versions of the full 218-amino-acid (aa) Tho1 pro-
tein, the 50-aa N-terminal region containing the SAP domain
(N-Tho1), and the 168-aa C-terminal part lacking the SAP
domain (Tho1-C). Such proteins were expressed in E. coli from
the T7 promoter and purified with Ni-nitrilotriacetic acid col-
umns in order to determine their nucleic acid binding proper-
ties in vitro.
The three polypeptides were purified (Fig. 5A), and RNA
binding was determined by gel-shifting assays using a 32P-
labeled 90-nucleotide RNA fragment synthesized in vitro. As
can be seen in Fig. 5B, the full Tho1 protein binds to RNA.
Band shifting was directly proportional to the amount of Tho1
protein used. This binding could be competed with cold RNA
in a manner proportional to the amount of cold RNA added,
whereas it was not competed by higher amounts of cold ssDNA
(Fig. 5C). Therefore, binding to RNA was specific rather than
a manifestation of unspecific binding to any type of single-
stranded nucleic acid. We therefore performed a more de-
tailed analysis to determine which region was conferring the
main ability of the protein to bind to RNA using the N-Tho1-
and Tho1-C-truncated versions. Figure 5D shows that although
the N-Tho1 version containing only the SAP domain had a
weak ability to bind RNA, the major RNA binding activity
resided in the C-terminal part of the protein outside of the
SAP domain, although no known RNA binding motif appears
in this region. As expected from its N-terminal SAP domain,
Tho1 also binds double-stranded DNA (see Fig. S3 in the
supplemental material).
Given these results, we tested the capacities of both trun-
cated Tho1 proteins to suppress the hpr1 mutation. For this,
we constructed new plasmids in which the N-Tho1- and
Tho1-C-encoding DNA sequences were fused to the regulated
GAL1 promoter. As can be seen in Fig. 5E, analysis of yeast
hpr1 transformed with these plasmids revealed that, whereas
N-Tho1 overexpression was unable to suppress the thermosen-
sitivity (ts) of hpr1, Tho1-C overexpression suppressed this ts
phenotype with a much better efficiency than did the whole
Tho1 protein.
Multicopy THO1 does not enhance Sub2 recruitment to
active chromatin. It has been shown that THO enhances the
ability of Sub2 to bind active chromatin, suggesting that THO
helps recruit Sub2 to the site of transcription (58). We there-
fore wondered whether the suppression of THO mutations by
multicopy THO1 was due to the capacity of Tho1 to help
recruit Sub2 to active chromatin. To test this possibility, we
assayed, by ChIP analysis, the ability of TAP-Sub2 to be re-
cruited to the PMA1 gene in hpr1 cells transformed with the
empty YEp351 vector or with the multicopy YEp351-THO1
carrying THO1. As can be seen in Fig. 6, the recruitment of
Sub2 to the two different PMA1 regions tested was reduced to
40 and 20% of the wild-type levels, regardless of whether the
hpr1 strains expressed THO1 in multicopy. Therefore, Tho1
does not stabilize or help to recruit Sub2 to the site of tran-
scription.
Genetic interaction of Tho1 with the Nab2 RNA binding
protein. Thus far, we were not able to identify a phenotype
associated with tho1 mutants and our identification of a role
of Tho1 in mRNP biogenesis derives from the effects caused by
Tho1 overexpression. Consequently, by directly studying the
effect of tho1 in double mutant combinations, we next deter-
mined whether THO1 could genetically interact with other
functions of mRNP biogenesis and export. We analyzed the
viability of double mutants of tho1 and mutations in genes
encoding different protein complexes that may act subse-
quently in the mRNP biogenesis pathway in which THO par-
FIG. 6. Effect of multicopy THO1 on Sub2 recruitment to active chromatin at the PMA1 gene in hpr1 and wild-type strains. ChIP analyses were
performed with strains BSU-S2T.3B (WT) and BSU-S2T.6D (hpr1) transformed with plasmid YEp351-THO1, carrying THO1 in multicopy or
the empty vector. Other details are as described for Fig. 3. Error bars indicate standard deviations. The PCR fragment corresponding to the bp
9716 to 9863 intergenic region of chromosome V used as a control is indicated by asterisks.
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ticipates, such as sub2, mex67-5, nab2-1, and thp1. These
single mutants show similar gene expression and hyperrecom-
bination phenotypes to those of THO mutants (16, 29). All
double mutants constructed were viable at 30°C (data not
shown), as was also shown for tho1 hpr1 mutants (45).
Interestingly, although tho1 nab2-1 had no phenotype at the
permissive temperature (30°C), tho1 suppressed the cryosen-
sitivity (cs) phenotype of nab2-1 cells. Thus, nab2-1 tho1 cells
formed colonies at 16°C, whereas nab2-1 did not (Fig. 7A), and
the nuclear poly(A) RNA accumulation phenotype observed
in nab2-1 mutants at 16°C was reduced in tho1 nab2-1 double
mutants (Fig. 7B). This result provides a demonstration that
the function of wild-type levels of Tho1 is related to RNP
biogenesis and export and establishes a functional link between
Tho1 and the Nab2 poly(A)-RNA binding protein.
DISCUSSION
This study reveals that Tho1, a SAF-box/SAP domain pro-
tein, is a nuclear hnRNP with a strong capacity to bind RNA at
its C-terminal half and that has a functional relationship to
THO and Sub2 in cotranscriptional mRNP biogenesis. Multi-
copy THO1, like SUB2, suppresses all phenotypes of THO-
complex mutants. As is the case for Sub2, Tho1 is specifically
recruited to active chromatin in a RNA- and THO-dependent
manner.
The functional relationship of Tho1 with the THO complex
suggests a function of Tho1 in mRNP biogenesis/processing
that is supported by the ability of Tho1 to bind RNA in vitro.
Despite the functional interconnection of Sub2 and Tho1, the
primary functions of both proteins may be different. Thus,
sub2 cells are either sick and thermosensitive or inviable,
depending on genetic background (19, 38), and show gene
expression and RNA export defects and a strong hyperrecom-
bination phenotype (13, 29). tho1 mutants are viable and
show no phenotypes and, whereas hpr1 sub2 mutants are invi-
able, hpr1 tho1 and sub2 tho1 are viable (45; data not shown).
Either the function of Tho1 in mRNP metabolism is redundant
or dispensable. Nonetheless, other genes with a putative role in
mRNP biogenesis and export for which only their overexpres-
sion and not their null mutation have a phenotype have been
defined. An example of that is Gbp2, which interacts physically
with the TREX complex (25, 53, 57).
Sub2 may be an RNA-dependent ATPase, as shown for the
human ortholog UAP56 (51) that forms, with the major RNA
binding protein Yra1, a heterodimer that physically associates
with THO in a larger complex termed TREX. The require-
ment of Sub2-Yra1 in RNA export has been well established
(52), and the associated phenotypes of gene expression defect
and transcription-dependent hyperrecombination conferred
by their mutations suggest that Sub2 function is essential for
the cotranscriptional formation of RNA export-competent
mRNPs. The association of Sub2 and THO with active chro-
matin is consistent with this idea. Although THO facilitates the
recruitment of Sub2 to active chromatin, multicopy THO1 does
FIG. 7. Deletion of THO1 rescues the cs phenotype and the mRNA export defects of nab2-1. (A) Tenfold serial dilutions of nab2-1 (NALT-1)
and tho1 nab2-1 (NALT-2) were spotted on selective plates and incubated at 16°C and 30°C for 5 days. (B) Subcellular localization of poly(A)
RNA detected in situ with digoxigenin-labeled oligo(dT)16. Other details are as described for Fig. 1.
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not suppress THO mutants by helping to recruit Sub2 nor
does it stabilize the TREX complex at the site of transcription
(Fig. 6). Nevertheless, we cannot rule out the possibility that
cotranscriptional Sub2 recruitment takes longer than usual in
the THO1-rescued hpr1 strains and is not detected cotrans-
criptionally. It is likely that Tho1 and Sub2 as well as the THO
complex function in vivo in a multiribonucleoprotein structure
at the site of transcription. In the absence of THO, overex-
pression of Tho1 or Sub2 may partially provide either a THO-
like function or an alternative pathway of mRNP biogenesis
and assembly. Overexpressed Tho1 or Sub2 may prevent the
undesired reactivity of nascent mRNA with template DNA
that has been observed in hpr1 mutants (24). The higher ac-
cumulation of Tho1 and Sub2 at the 3 ends of transcribed
coding regions (Fig. 4) (58) opens the possibility that Tho1 and
Sub2 might also be important for transcription termination or
3-end processing. Interestingly, we have recently found a ge-
netic and functional interaction between THO and the RNA
cleavage and polyadenylation factors (40).
The observation that multicopy THO1 does not suppress
sub2 but only THO mutations suggests that the THO com-
plex constitutes a functional unit independent of Sub2-Yra1
RNA export factors. This is consistent with the facts that THO
is a stable complex in the absence of Sub2 (29), whereas THO
becomes unstable in hpr1 mutants (our unpublished obser-
vation). Tho1 cannot substitute for Sub2 in the cell, only for
THO. Indeed THO has been shown to copurify with Sub2 in
yeast and humans, but this has not been possible yet for Dro-
sophila THO (47) and recent evidence suggests that human
THO components can be purified free of UAP56/Sub2 and
Yra1/ALY (42). These results are in agreement with the ob-
servations that only Sub2 but not THO complex recruitment to
chromatin depends on RNA (1), suggesting the possibility that
the association of THO with Sub2-Yra1 in the TREX complex
might be mediated by the mRNA molecule.
Tho1 may belong to a SAP/SAF-box class of hnRNPs with a
function related to mRNP biogenesis and export. Indeed, the
SAP domain was identified in scaffold-associated proteins (7)
such as SAF-A/hnRNPU, which is an RNA binding protein
that copurifies with RNAPII and cooperates with actin for
productive transcription by RNAPII (31, 34), and SAF-B,
which interacts with SR proteins and affects splicing in vivo
(44). Nevertheless, the observation that overexpression of the
RNA binding C-terminal half of Tho1 suppresses hpr1 more
efficiently than the whole Tho1 protein, whereas overexpres-
FIG. 8. Model explaining the roles of the THO complex, Sub2, and
Tho1 in mRNP cotranscriptional mRNP biogenesis in different genetic
backgrounds. (A) In wild-type cells, the THO complex would facilitate
loading of the Sub2-Yra1 heterodimers onto the nascent mRNA. Nu-
merous Sub2 molecules are recruited onto the mRNA molecule as it is
extended, allowing the formation of an export-competent mRNP,
which is exported by Mex67-Mtr2. (B) In the absence of a functional
THO complex, Sub2 is not loaded properly onto the nascent mRNA
and only a few molecules gain access to the RNA by a THO-indepen-
dent low-affinity mechanism. As a consequence, an improperly assem-
bled export-incompetent mRNP is generated, which could form DNA-
RNA hybrids behind the elongating RNAPII. (C) In the absence of a
functional THO complex, overexpression of Sub2 increases the prob-
ability of Sub2 or Sub2-Yra1 to directly bind to the nascent mRNA,
bypassing the requirement of THO to assemble an export-competent
mRNP. (D) Overexpression of the Tho1 hnRNP will allow loading of
Tho1 onto the nascent mRNA in the absence of THO complex. An
alternative export-competent mRNP molecule would be formed with
the essential Sub2-Yra1 subunits loaded in a THO-independent man-
ner. This would explain why sub2, in contrast to THO null mutations,
cannot be suppressed by multicopy THO1.
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sion of the SAF-box has no effect (Fig. 5), indicates that the
RNA binding C-terminal half of Tho1, rather than the SAP
domain, is primarily responsible for its mRNP biogenesis/ex-
port-related function.
Two additional observations support that Tho1 is an hnRNP
with a role in mRNP biogenesis and export. The putative
structural homolog of Tho1 in humans is a nuclear-matrix
protein, Hcc-1 (see Fig. S2 in the supplemental material),
which has been shown in two-hybrid assays to bind the two
DEAD box putative RNA helicases, hSUB2/UAP56/BAT1
and DDX39 (12, 35). Whether Tho1 might interact with RNA-
dependent ATPases important in the assembly of export-com-
petent mRNPs is a possibility to be explored. It has been
reported in a high-throughput two-hybrid analysis that Tho1
and Sub2 interact (26), and we have observed that His6-tagged
Tho1 purified from E. coli coimmunoprecipitates with Sub2
(unpublished data). The physiological relevance of this inter-
action is not clear and needs further investigation since Tho1
overexpression does not enhance Sub2 recruitment (Fig. 6)
and we cannot discard the possibility that such Sub2-Tho1
interaction could be mediated by RNA. It is also interesting to
note that Tho1 coprecipitates with many other factors involved
in mRNA metabolism with a Flag-tagged Spt5 transcription
factor (39).
Thp1-Sac3 is a nuclear protein complex located at nuclear
pores, and the mutation of any of its components has been
shown to lead to similar phenotypes in gene expression and
genomic instability to those of THO mutants (14, 16). The
overexpression of Nab2, a poly(A) binding hnRNP, sup-
presses thp1 mutations (16), and interestingly, tho1 sup-
presses the cryosensitivity cs phenotype of nab2-1. Like tho1,
null mutations of the two tetratricopeptide repeat-like proteins
Mlp1/Mlp2 attached to the nuclear pores suppress the ts phe-
notype of the N-terminal deletion of NAB2 (56). One possible
explanation for this result is that Tho1 could facilitate Nab2
loading onto the mRNP particle. In this scenario, Nab2-1 mu-
tant protein could form a suboptimal mRNP particle that
would not be exported from the nucleus and would be de-
graded. A role for Mlp1/Mlp2 in the control of export and
degradation of unprocessed mRNAs has been proposed
(17). The genetic interaction between Tho1 and Nab2
strengthens the possibility that Tho1 functions along the
mRNP biogenesis process from the DNA to the nuclear
pore, establishing a further link between transcription and
RNA export as well as between THO and Thp1-Sac3.
Considering all results, we suggest a working hypothesis in
which the THO complex would facilitate loading of Tho1 and
Sub2-Yra1 onto the nascent mRNA (Fig. 8). Consistent with
the high abundance of Sub2 per cell (18) numerous Sub2
molecules could be recruited onto the nascent mRNA mole-
cule as it is extended, allowing formation of an export-compe-
tent mRNP (Fig. 8). In the absence of a functional THO
complex, only a few Sub2 subunits would gain access to the
RNA by a THO-independent, low-affinity mechanism leading
to an export-incompetent suboptimal mRNP that could form
DNA-RNA hybrids behind the elongating RNAPII. Efficient
recruitment of Tho1 onto the nascent mRNA would also re-
quire THO. In THO mutants, there would be two alterna-
tives. Sub2 overexpression would increase its own probability
to bind to the nascent mRNA, bypassing the requirement of
THO to assemble an export-competent mRNP. Tho1 overex-
pression would allow low-affinity recruitment of Tho1 to yield
an export-competent mRNP with the essential Sub2-Yra1 het-
erodimers loaded in a THO- and Tho1-independent manner.
The model is consistent with the idea that Yra1 would be the
adapter to the Mex67/Mtr2 export factor responsible for the
export of the mRNP in all scenarios considered. Whether Tho1
has a structural role in mRNP formation and export or has a
biochemical activity required to catalyze a particular step of
mRNP biogenesis and export will have to be deciphered in the
future.
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